An observational monocentric study assessing the effectiveness of Ustekinumab in patients with refractory perianal Crohn's disease
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 07 Dec 2021 New trial record